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A B S T R A C T
Digital breast tomosynthesis (DBT) is currently under consideration for replacement of, or combined use with
2D-mammography in national breast screening programmes. To investigate the potential beneﬁts that DBT can
bring to screening, the threshold detectable lesion diameters were measured for diﬀerent forms of DBT in
comparison to 2D-mammography. The aim of this study was to compare the threshold detectable mass diameters
obtained with narrow angle (15°/15 projections) and wide angle (50°/25 projections) DBT in comparison to 2D-
mammography. Simulated images of 60mm thick compressed breasts were produced with and without masses
using a set of validated image modelling tools for 2D-mammography and DBT. Image processing and re-
construction were performed using commercial software. A series of 4-alternative forced choice (4AFC) ex-
periments was conducted for signal detection with the masses as targets. The threshold detectable mass diameter
was found for each imaging modality with a mean glandular dose of 2.5 mGy. The resulting values of the
threshold diameter for 2D-mammography (10.2 ± 1.4mm) were found to be larger (p < 0.001) than those for
narrow angle DBT (6.0 ± 1.1mm) and wide angle DBT (5.6 ± 1.2mm). There was no signiﬁcant diﬀerence
between the threshold diameters for wide and narrow angle DBT. Implications for the introduction of DBT alone
or in combination with 2D-mammography in breast cancer screening are discussed.
1. Introduction and background
Digital breast tomosynthesis (DBT) involves the acquisition of two-
dimensional X-ray projections of the breast over a limited angular range
and their reconstruction to image planes parallel to the detector [1–5].
It exposes the patient to similar dose levels to those of 2D-mammo-
graphy [6] and is currently under consideration for its use in breast
cancer screening in combination with 2D-mammography or alone in
several countries in Europe. For DBT to be combined with 2D-mam-
mography in breast screening it would require the additional dose due
to DBT to be justiﬁed in terms of overall reduction in mortality and
morbidity. For DBT to replace 2D-mammography in screening it would
have to at least provide the same detectability of cancer lesions as 2D-
mammography.
Some clinical observer studies have shown that with DBT, and
especially for masses, there is an increase in sensitivity, and a sig-
niﬁcant reduction in speciﬁcity [7–10], while others have shown no
change in sensitivity [11–13] and no signiﬁcant increase in speciﬁcity
[12,14]. Clinical observer studies have the advantage of high clinical
relevance, however, there are conﬂicting conclusions in the literature.
Furthermore, clinical studies can be time consuming, potentially sub-
ject to a number of confounding factors, expensive and do not always
allow the evaluation of speciﬁc imaging technology metrics (for ex-
ample, detectable lesion diameter), due to, for example, the limited
number of suﬃciently small lesions. The comparison of diﬀerent ima-
ging protocols using the same cohort of women can also be challenging,
due to the ethical issues that exist in exposing one woman to diﬀerent
image acquisition methods.
Alternatively, simulation methods are sensitive and useful for in-
vestigating the imaging technology. Observer studies with lesions in-
serted into physical phantoms (anthropomorphic or structured) [15,16]
or fully simulated breast images [17–20] have yielded useful results,
while image metrics such as contrast-to-noise ratio (CNR), CNR/ASF
(artefact spread function) [21–23] have also been used successfully.
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Simulation studies have shown that masses were visible at a lower
contrast than with 2D-mammography in comparison to DBT [17,20]. In
the recent work of Hadjipanteli et al [18] three commercially-im-
plemented geometries (2D-mammography, narrow angle (15°/15 pro-
jections) and wide angle (50°/25 projections)) were compared. It was
shown that 2D-mammography demonstrated a smaller minimum de-
tectable calciﬁcation diameter than either DBT geometry, and narrow
angle DBT showed a smaller minimum detectable calciﬁcation diameter
than wide angle DBT. This might be explained by the higher resolution
(higher MTF) that the 2D-mammography system exhibited compared to
that for the DBT systems investigated [24], which was advantageous for
the detection of small objects such as micro-calciﬁcations. For the de-
tection of larger objects DBT has the advantage of reducing the ap-
pearance of overlying structures in the image [4] but the beneﬁt of this
in terms of minimum detectable mass size against a clinically realistic
background has not been quantiﬁed in an observer study.
The aim of this work therefore was to use a simulation-based ob-
server study to quantify the threshold detectable mass diameter for 2D-
mammography, narrow and wide angle DBT. For this purpose we si-
mulated the images of a voxel phantom [25] with inserted masses to
create realistic simulated images. An advantage of this approach is that
the same breast can be imaged using diﬀerent acquisition methods,
unlike clinical studies. We aimed to expand on the results of a previous
observer study [18] conducted for the detection of calciﬁcations and
used the same methods to assess the same systems for the detection of
masses. Knowledge of the threshold detectable mass diameter, in ad-
dition to calciﬁcation diameter, of the three imaging systems would
help quantify the diﬀerences between DBT (narrow and wide angle)
and 2D-mammography imaging and make a clinically relevant com-
parison between diﬀerent imaging systems for diﬀerent forms of breast
cancer.
2. Methods and materials
In this study, validated simulation methods [26] were used to assess
the detectability of masses in 2D-mammography and DBT. These
methods involve the realistic simulation of breast images with and
without masses and their use in 4-alternative forced choice (4-AFC)
observer studies. The values of the threshold detectable mass diameter
determined from the observer studies were compared for each mod-
ality. Dose, breast glandularity, breast thickness, mass insertion height
and the processing or reconstruction software used (which can all aﬀect
lesion detectability) were ﬁxed for the three modalities tested, so that
only the eﬀect of system geometry on mass detectability was assessed.
The simulation involved three stages: creation of voxel phantoms of
the breast, creation and insertion of simulated masses into the
phantoms, and the creation of images. These stages, together with the
4-AFC methodology and analysis, are described in Sections 2.1–2.5
below.
2.1. Mathematical breast phantom
For consistency with the methods followed by Hadjipanteli et al
[18], we used six realistic mathematical breast phantoms validated for
4-AFC studies [25]. The breast phantoms were produced using a bio-
logical approach in which breast components were simulated using
features extracted from clinical DBT images. The components simulated
were the skin, adipose tissue, ﬁbro-glandular tissue, Cooper’s ligaments
and blood vessels. Clinical breast readers were unable to distinguish
simulated image patches produced using these phantoms from
equivalent image patches from real mammograms and DBT images.
Furthermore, the statistical properties of simulated images showed a
strong match to those of real images [25].
The phantoms had a voxel size of 100 μm×100 μm×100 μm. The
phantom shape was based on a real compressed breast and its 2D-size
was 240mm (chest wall direction)× 120mm (nipple direction). Each
breast phantom had a compressed breast thickness (CBT) of 60mm and
a glandularity of between 17% and 19% by volume in each patch. This
volume glandularity was chosen as it is equivalent to the average
glandularity of 21% by mass in the central portion of the breast for
women of age 50 to 64 with CBT of 60mm attending the UK breast
screening programme [27].
2.2. Simulated masses
Simulated masses were produced using a fractal growth method
known as diﬀusion limited aggregation [28]. Fig. 1 shows the 3D ren-
dered mass and the 2D projections of the mass for diﬀerent diameters.
Eleven diﬀerent masses of the same density were replicated three times
each by rotation through 90°, 180° and 270°, creating 44 unique masses
of a selected diameter. The attenuation properties of the masses were
assumed to be the same as glandular tissue. The masses were then
scaled and set to average diameters ranging from 4.7 to 10.3mm and
inserted into the breast phantoms by voxel replacement at a random
location at least 10mm from the skin edge and at a constant height,
30mm, above the breast support.
2.3. Image simulation
The modelling tools used to calculate simulated images of the breast
phantoms included a ray tracing tool, a scatter prediction tool and an
image degradation tool [26]. These are brieﬂy described below. More
(a)                   (b)                      (c)     (d)  
Fig. 1. Simulated mass: a) 3D rendering of mass; 2D projection images of isolated masses of average diameters (a) 6.6 mm, (b) 8.4 mm and (c) 10.3 mm before
insertion into the mathematical breast phantom.
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details can be found in Hadjipanteli et al [18].
The narrow angle DBT geometry tested used a 15°/15 projections
conﬁguration, based on the DBT geometry of the Hologic Selenia
Dimensions X-ray set. The wide angle DBT geometry tested used a wide-
angle and high number of projections (50°/25 projections) conﬁgura-
tion, also based on an existing commercial geometry (Mammomat
Inspiration, Siemens Medical Solutions, Erlangen, Germany). The
number of projections and source movement blurring matched the
commercial system. In this way, an attempt was made to compare the
clinical geometry of Hologic (narrow angle DBT) to a possible wider-
angular range geometry, which is realistic and is based on an existing
geometry. The image receptor was represented as an amorphous sele-
nium detector for both 2D-mammography and the two DBT geometries
being simulated (Selenia Dimensions, Hologic Inc., Bedford, MA). Thus
the same detector and X-ray spectrum were used for both DBT conﬁg-
urations. The physical pixel pitch of the detector was 0.07mm for 2D-
mammography and 0.14mm for narrow and wide angle DBT following
pixel binning.
Clinically used tube voltage and target/ﬁlter materials were simu-
lated for the X-ray source: (i) 2D-mammography: 31 kVp W/Rh; (ii)
DBT: 33 kVp W/Al. Additional aluminium attenuation was used to at-
tenuate the spectra to match the experimentally measured half value
layers of 0.55mm Al for 2D-mammography and 0.59mm Al for narrow
and wide angle DBT.
For each spectrum, the incident air kerma was calculated at the
entrance of the breast and the mean glandular dose (MGD) was com-
puted using conversion factors from Dance et al [27,29], based on the
standard methods adopted in UK and EU breast dosimetry protocols in
mammography [30,31] and DBT [32]. MGD was ﬁxed at 2.5mGy for all
three modalities [6].
The primary images/projections were produced using a ray tracing
tool developed for 2D-mammography and DBT [26]. The ray tracing
simulation included transmission through the anti-scatter grid (in 2D-
mammography only), geometric blurring due to focal spot ﬁnite size
(0.4× 0.4mm2). Blurring due to tube movement was taken into ac-
count by stretching the focal spot in the direction of movement, such
that the focal spot size was 0.4×1.4mm2 for the narrow angle DBT
and 0.4× 2.2mm2 for wide angle DBT in the direction of tube move-
ment.) Focal spot size values were based on experimental measure-
ments of the exposure time and tube movement. The attenuation by the
breast support and compression paddle was also taken into account.
Breast movement was not included.
A pre-calculated table of the scatter-to-primary ratios (SPR) derived
from Monte Carlo measurements of scatter was used for the calculation
and incorporation of scatter in the images. This had been previously
validated as part of an image simulation framework [26].
The image degradation tool was based on the methods of Mackenzie
et al [33,34]. These use measurements of signal transfer properties
(STP), pre-sampled modulation transfer function (MTF), noise power
spectrum (NPS) and ﬂat ﬁeld correction map to adapt the image quality
of the simulated images.
It was not possible to use vendor speciﬁc reconstruction software for
both the narrow and wide angle DBT. Therefore, the images were
processed and reconstructed using generic software from Real Time
Tomography, LLC, (Philadelphia, USA), due to the ﬂexibility in pro-
cessing diﬀerent DBT geometry conﬁgurations. The 2D images were
processed using Adara and the DBT planes were reconstructed using
Briona, which used ﬁltered back-projection for reconstruction of the
tomosynthesis image planes. After post processing, the 2D-mammo-
graphy images and DBT planes were cropped into 30mm×30mm
image patches, randomly selected away from the edges of the whole
breast image, to be used in the human observer experiments. For DBT,
12 planes were used, centred on the centre of the mass volume. A pilot
study was undertaken to aid the selection of three mass diameters to be
inserted into the images for each modality to give detection rates be-
tween 30% and 95% for each. To achieve the required detection rates,
the mass diameters used were: 2D-mammography: 8.4mm, 9.4 mm and
10.3 mm; and narrow and wide angle DBT: 4.7mm, 5.6 mm and
6.6 mm. In total, 396 cropped images (44 images× 3 diameters× 3
modalities) each with a mass were produced. In addition, 1768 back-
ground cropped images were produced without an inserted mass for
each modality.
2.4. Observation and 4AFC study
Five physicists participated in a series of 4AFC human observer
experiments. As this was a forced choice study and does not include the
eﬀect of ‘searching’ or interpretation, non-radiologists as observers
were acceptable. Elangovan et al [20] found that although radiologists
had a slightly better detection rate in 4-AFC studies than non-radi-
ologists, there were no diﬀerences in the overall conclusions about the
eﬀect of diﬀerences in technology. An in-house Java-based plug-in
(ImageJ 1.50i, NIH, USA) was used to run the 4AFC study (Fig. 2). Sets
of four 30mm×30mm breast phantom 2D-mammography cropped
images or DBT planes were randomly selected and presented in turn to
each observer. In each set, one image contained a mass in the centre
and the other three did not. The observers were required to identify
which of the four images contained the mass and register their decision
by selecting the relevant quadrant. A 2D projection of the inserted 3D
mass (reference copy of the signal or “image cue”) was also shown
isolated from the background. In the DBT 4AFC studies the observer
was able to scroll through 12 planes. Each observer was shown 132
groups of four images for each modality. Within these 132 groups, 44
Fig. 2. Screenshot of software used in 4AFC study. The reference copy is shown
above the four quadrants of which one contains a mass. The mass is in the top-
right hand corner.
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cases were presented for each of the three diﬀerent mass diameters to
the observer in a random order.
As in clinical practice, a high-resolution reporting quality monitor
(Barco, B-8500, 5MP, Belgium) was used for the experiments. All
images were displayed at 100% magniﬁcation (one-to-one pixel map-
ping between the image and the monitor), low lighting levels were used
and no time limit was imposed.
2.5. Analysis
A linear relationship was assumed between the mass diameter and
detectability, based on the Rose Model [35,36]. The detectability was
expressed numerically in terms of the detectability index (d'), a quantity
related to the visibility of a lesion. The d' can be found in look-up tables
in Macmillan and Creelman [37] from the percentage of correct de-
tection decisions (PC) for an observer in a 4-AFC study. The threshold
detectable mass diameter was taken as the size at which the observer
makes 90.7% correct decisions, and which corresponds to a d' of 2.5
[37]. For each observer a linear least square ﬁt for d' versus mass dia-
meter was used to ﬁnd the threshold detectable mass diameter (at a d' of
2.5) and the overall mean threshold detectable mass diameter for each
modality was calculated. For comparison, the threshold detectable mass
diameter for each modality at a PC of 62.5% (corresponds to a d' of 1.2),
the value used for reading the CDMAM phantom [38], was also cal-
culated. If the measured detection rate was above 62.5% for all mass
diameters, the calculated threshold diameter required an extrapolation
of the ﬁtted straight line between d’ and mass diameter.
Errors in PC were calculated from the 95% conﬁdence intervals on
the measured PC values assuming a binomial distribution and N=44
for each observer. This provided a range of uncertainty in PC for each
observer, which was translated (through the relation of PC to d') to a
range of uncertainty in d' and the threshold detectable mass diameter
value for each observer (through the linear least square ﬁt). The error in
the overall mean threshold detectable mass diameter for each modality
was set equal to the root mean square error of the uncertainty in
threshold detectable mass diameters of the ﬁve observers, over the
square root of ﬁve. Analysis of variance (ANOVA) was performed to
identify any statistically signiﬁcant diﬀerences between the threshold
detectable mass diameters for the three imaging modalities and to test
for diﬀerences between the observers.
3. Results
Fig. 3 shows examples of the simulated images for (a) 2D-mam-
mography, (b) narrow and (c) wide angle DBT, used in the observer
studies.
Fig. 4 shows the dependence of the detectability index, d' on the
mass diameter for wide angle DBT for each observer. For the least
squares ﬁts shown in the ﬁgure, the goodness of ﬁt, in terms of the
square of the Pearson product moment correlation coeﬃcient, R2 was
found to be between 0.80 and 0.99 for all modalities and observers.
The threshold detectable mass diameters for the ﬁve observers and
the three imaging modalities, at a MGD of 2.5mGy and with a height of
insertion of 30mm above the breast support, are presented in Fig. 4 (a).
ANOVA analysis produced a p-value of 0.65 for the eﬀect of the var-
iation between the observers, showing conﬁdence in the rejection of the
hypothesis that there is a signiﬁcant diﬀerence in the threshold de-
tectable mass diameters estimated for the ﬁve observers. The diﬀerence
between the three modalities for each observer is shown in Fig. 5(a).
Fig. 5(b) shows the averages of the observers’ results for each modality
at PC values of 62.5% and 90.7%. It can be seen that DBT performs
better than 2D-mammography and wide angle DBT performs margin-
ally better than narrow angle DBT (for both a PC of 90.7% and 62.5%).
There was a highly signiﬁcant diﬀerence between the threshold mass
diameter that can be detected by 2D-mammography and DBT
(p < 0.0001). When comparing the results at a PC of 90.7% to those
for a PC of 62.5% a diﬀerence of 2.1–2.5mm was found depending on
modality.
4. Discussion
In this study, the threshold detectable mass diameter for three dif-
ferent existing geometries of breast imaging systems have been quan-
tiﬁed through 4AFC observer studies for the same 60mm thick breasts.
The comparison methods used oﬀered the key advantage of allowing
precise control over the variables under investigation, which would be
impossible under a conventional clinical trial. We used human ob-
servers viewing images of the same breast tissue for the comparison of
diﬀerent systems, thereby eliminating variability in subject background
and target appearance, over and above the particular variable under
consideration: threshold diameter. Moreover such a simulation-based
approach is far less time and resource hungry than clinical trials.
However, the 4AFC methodology does limit the number of acquisition
methods that can be practicably studied. Other authors [21,23] used
Fig. 3. Example images of masses inserted into mathematical breast phantoms and following the image simulation of (a) 2D-mammography, (b) narrow and (c) wide-
angle DBT. The sizes of the masses are (a) 6.6 mm (b) 10.3 mm (c) 10.3 mm.
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image metrics (e.g. contrast to noise ratio (CNR), CNR/ASF (artefact
spread function)) instead of observer experiments to assess the visibility
of calciﬁcations and tested more geometries. However, such an ap-
proach lacks the link to the detection performance of a real observer.
DBT was found to have a lower threshold detectable mass diameter
than 2D-mammography (p-value of < 0.0001), whichever choice of PC
was made; 90.7% or 62.5%, although the threshold values are higher
for the higher PC choice. The order of performance of the systems
agrees with a previous 4AFC observer study [20], carried out using
methods similar to those used in the current study, but which used
Hologic reconstruction software instead of Briona reconstruction soft-
ware, and which evaluated the signal contrast needed to correctly
identify a mass, instead of the threshold detectable mass diameter.
Elangovan et al [20] showed that observers needed over three times the
signal contrast to correctly identify a mass in 2D-mammography com-
pared with DBT (narrow angle). The work by Mackenzie et al [19] used
similar methods to quantify the minimum detectable mass diameter for
2D-mammography and DBT for the Siemens Inspiration system (which
has the wide-angle geometry used in this study). Their conclusions
agree with our work in that DBT has a smaller detectable mass diameter
than 2D-mammography. However, numerically, there are diﬀerences in
the results (2D-mammography 6.3mm, wide-angle DBT: 4.9mm, for a
PC of 90.7%), from these latest results, which might be partly explained
by the using a thinner CBT of 53mm and that the simulated system was
based entirely on the Siemens Inspiration, including the manufacturer’s
processing and reconstruction software and pixel size. In our study,
Briona processing and reconstruction software were used, instead of the
manufacturer’s software used by Mackenzie et al.
Our results clearly conﬁrm the advantage of DBT over 2D-mam-
mography for mass detection. However, they also raise a concern for
either DBT or 2D-mammography being used alone in breast screening
as each better visualises a diﬀerent form of breast cancer. 2D-mam-
mography appears to oﬀer higher detectability of small calciﬁcations
[18] and DBT appears to oﬀer superior performance for the detection of
small masses. Even though the DBT images may be less sharp than 2D-
mammography images, as the modulation transfer function (MTF) for
some systems is lower [24], DBT still favours the detectability of
masses, due to the ability to remove or reduce the appearance of
overlapping structures in image planes of the breast tissue being im-
aged.
The results of this study suggest that if 2D-mammography were used
alone in screening, it could miss masses that would be visible with DBT.
However, by also considering the results in Hadjipanteli et al [18], if
DBT alone is used it could miss small calciﬁcations, which would be
visible with 2D-mammography. 2D-mammography could be used alone
at an increased dose, but there is evidence to support that changing
dose does not signiﬁcantly change mass detection levels [39]. Alter-
natively, if DBT alone is used at double the standard dose level (5 mGy),
so that an increased calciﬁcation detection is provided, the threshold
detectable calciﬁcation diameter would still not be as small as that that
can be provided by 2D-mammography [18]. The choice of the imaging
methods seems more important than dose. On the other hand, the
combined use of both 2D-mammography and DBT in screening has the
advantage of adding the newest technology available for a further
beneﬁt in early diagnosis, but at a cost of increased radiation dose to a
largely healthy screening population. A potential solution may lie in the
use of synthetic imaging, which provides the generation of a synthe-
sised 2D image from DBT data (and thus eliminating the use of 2D-
mammography), and is available from some manufacturers. There are
on-going studies on the use of synthetic imaging in screening [40–43]
and the identiﬁcation of its strengths and weaknesses [44].
This study also provided a comparison between an existing narrow
Fig. 4. The dependence of the detectability index, d', on mass diameter for wide angle DBT for the ﬁve observers. The vertical lines show the mass diameters at a
detectability index of 2.5, which was taken as the threshold detectable mass diameter. Vertical dotted lines show the corresponding mass diameter for each observer
where d' = 2.5. Error bars were calculated from the 95% conﬁdence intervals on the measured PC values assuming a binomial distribution and N=44 for each
observer and translated to d' values.
A. Hadjipanteli et al. Physica Medica 57 (2019) 25–32
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angle DBT and a wide angle DBT system when the same image receptor
and X-ray spectrum are used. Wide-angle DBT was found to have a
marginally smaller (but not signiﬁcantly diﬀerent) threshold mass
diameter than narrow-angle DBT. Goodsitt et al [22] found that ob-
servers preferred images acquired with the wide angle (60°, 21 pro-
jections) as opposed to narrow angle geometries (16 °, 17 projections)
for low contrast objects such as masses. Similarly, Sechopoulos and
Ghetti [21] and Tucker et al [45] found best performance for mass-like
objects at the widest angle in their studies. Even though the wide angle
DBT geometry might introduce an increased geometric blurring as the
projection angle becomes wider [46], the dose per projection is de-
creased and the relative quantum and electronic noise in each projec-
tion is increased, it was still advantageous over narrow angle DBT. By
increasing the DBT scan angular range, depth resolution improves [47].
Wider scan angles with more projections (for an adequate sampling of
image data and fewer tomosynthesis reconstruction artefacts), in-
creased relative quantum noise and insuﬃcient angular sampling can
have a negative eﬀect on the detectability of small-scale signals [48].
However, for the detectability of large-scale objects like masses, this
eﬀect might not be important.
As with all virtual clinical trials to date, limitations of this study
include omitting any breast movement in the simulations of the three
imaging modalities. Also, the image simulation did not include any lag
or ghosting eﬀects for the DBT images. It is not expected that lag and
ghosting would signiﬁcantly aﬀect the conclusions of this study, as lag
has negligible eﬀect on image noise, and it is not expected that the
eﬀect it has on MTF [24] will aﬀect the ability to resolve objects with
the size of masses we used in this study. The simulation could be im-
proved by reducing the size of the voxels and increasing the number of
simulated rays per pixel. Similarly, Monte Carlo simulation could have
been used to calculate scatter in the breast phantoms used, instead of
assuming a constant scatter contribution across the whole image patch.
For reasons of practicality we used a simple approach to estimate
scatter as in all cases the patches were small and positioned away from
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the edges of the whole image. Any systematic error that might have
been introduced in the total signal of the image is expected to be similar
for both the DBT geometries considered, but could lead to a small dif-
ference in the performance comparison between 2D and DBT. Another
potential limitation is that we used Briona for the image and re-
construction software rather than the system manufacturer’s software.
Therefore it could be claimed that it does not fully represent clinically
applicable processing. However, quantitative analysis (full width at half
maximum, contrast-to-noise ratio (CNR), contrast degradation factor)
and qualitative tests on DBT images that included objects reconstructed
using Briona showed that it produced images comparable to those
produced by reconstruction and processing software used clinically
(Hologic Selenia Dimensions).
5. Conclusions
This study used a quantitative approach with observers viewing
simulated masses imaged in clinically realistic backgrounds to compare
diﬀerent DBT geometries and 2D imaging. The methodology employed
a set of validated tools to ensure clinically relevant conclusions. The
results showed no signiﬁcant diﬀerence between the performance of
narrow and wide angle DBT for the detection of masses and that both
DBT acquisition methods had a smaller threshold detectable mass dia-
meter than 2D-mammography. This raises concerns on the use of 2D-
mammography alone in screening, while the addition of DBT could add
some beneﬁt, but also, a risk of higher dose eﬀects in the screening
population. Further studies are required for the assessment of the
overall beneﬁt of using DBT in breast screening, either alone or in
conjunction with 2D imaging.
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